These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
329 related items for PubMed ID: 11274536
21. Importance of small (< or = 20-mm) enhancing lesions seen only during the hepatic arterial phase at MR imaging of the cirrhotic liver: evaluation and comparison with whole explanted liver. Holland AE, Hecht EM, Hahn WY, Kim DC, Babb JS, Lee VS, West AB, Krinsky GA. Radiology; 2005 Dec; 237(3):938-44. PubMed ID: 16306035 [Abstract] [Full Text] [Related]
22. Hepatic hemangioma and metastasis: differentiation with gadoxetate disodium-enhanced 3-T MRI. Goshima S, Kanematsu M, Watanabe H, Kondo H, Shiratori Y, Onozuka M, Moriyama N. AJR Am J Roentgenol; 2010 Oct; 195(4):941-6. PubMed ID: 20858822 [Abstract] [Full Text] [Related]
37. Splenic hemangiomas and hamartomas: MR imaging characteristics of 28 lesions. Ramani M, Reinhold C, Semelka RC, Siegelman ES, Liang L, Ascher SM, Brown JJ, Eisen RN, Bret PM. Radiology; 1997 Jan; 202(1):166-72. PubMed ID: 8988207 [Abstract] [Full Text] [Related]
38. Perilesional enhancement of liver cavernous hemangiomas in magnetic resonance imaging. Sousa MS, Ramalho M, Herédia V, Matos AP, Palas J, Jeon YH, Afonso D, Semelka RC. Abdom Imaging; 2014 Aug; 39(4):722-30. PubMed ID: 24531350 [Abstract] [Full Text] [Related]
39. Hepatic hemangiomas: a multi-institutional study of appearance on T2-weighted and serial gadolinium-enhanced gradient-echo MR images. Semelka RC, Brown ED, Ascher SM, Patt RH, Bagley AS, Li W, Edelman RR, Shoenut JP, Brown JJ. Radiology; 1994 Aug; 192(2):401-6. PubMed ID: 8029404 [Abstract] [Full Text] [Related]